Hyundai Bioscience Co., Ltd. - ROE
048410.KQ
Price:
$6650
Market Cap:
$641.75B
Hyundai Bioscience Co., Ltd. is a biotechnology firm dedicated to creating and commercializing bio-fusion technologies that enable the precise delivery of active compounds throughout the human anatomy. The company offers Vitabrid C12, a novel vitamin C product engineered to provide active vitamin C directly to the skin. Additionally, it is advancing organic-inorganic hybrid technology, which functions as a sophisticated drug delivery system. This system integrates bio-friendly minerals to ensure the targeted and efficient transport of active substances to specific sites, a capability also leveraged in its anticancer drug carrier innovations. The enterprise was established in 2000 and is head...[Read more]
Industry
Biotechnology
IPO Date
2002-08-28
Stock Exchange
KOE
Ticker
048410.KQ
PE Ratio
[-29.41]
ROE
[-24.26%]
Current Ratio
[2.36]
Dividend Yield
[0%]
Enterprise Value
[647.46B]
Dividend History
The ROE as of August 2026 (TTM) for Hyundai Bioscience Co., Ltd. (048410.KQ) is -24.26%
According to Hyundai Bioscience Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -24.26%. This represents a change of 296.41% compared to the average of -6.12% of the last 4 quarters.
Hyundai Bioscience Co., Ltd. (048410.KQ) Historical ROE (quarterly & annually)
How has 048410.KQ ROE performed in the past?
The mean historical ROE of Hyundai Bioscience Co., Ltd. over the last ten years is -17.74%. The current -24.26% ROE has changed 36.71% with respect to the historical average. Over the past ten years (40 quarters), 048410.KQ's ROE was at its highest in in the December 2018 quarter at 6.27%. The ROE was at its lowest in in the December 2016 quarter at -31.97%.
Average
-17.74%
Median
-18.78%
Minimum
-44.39%
Maximum
6.47%
Hyundai Bioscience Co., Ltd. (048410.KQ) ROE by Quarter and Year
Discovering the peaks and valleys of Hyundai Bioscience Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 106.35%
Maximum Annual ROE = 6.47%
Minimum Annual Increase = -1633.39%
Minimum Annual ROE = -44.39%
| Year | ROE | Change |
|---|---|---|
| 2025 | -19.99% | 13.77% |
| 2024 | -17.57% | -45.14% |
| 2023 | -32.03% | 17.99% |
| 2022 | -27.14% | -16.65% |
| 2021 | -32.57% | 106.35% |
| 2020 | -15.78% | -1082.40% |
| 2019 | 1.61% | -75.18% |
| 2018 | 6.47% | 63.93% |
| 2017 | 3.95% | -108.89% |
| 2016 | -44.39% | -1633.39% |
Hyundai Bioscience Co., Ltd. (048410.KQ) Average ROE
How has 048410.KQ ROE performed in the past?
The current ROE of Hyundai Bioscience Co., Ltd. (048410.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.20%
5-year avg
-25.86%
10-year avg
-17.74%
Hyundai Bioscience Co., Ltd. (048410.KQ) ROE vs. Peers
How is 048410.KQ’s ROE compared to its peers?
Hyundai Bioscience Co., Ltd.’s ROE is greater than Komipharm International Co., Ltd. (-3.64%), greater than i-SENS, Inc. (-0.98%), less than Humedix Co., Ltd. (15.52%), greater than BINEX Co., Ltd. (-16.37%), less than Huons Global Co., Ltd. (4.13%), less than Proteina Co., Ltd. (0%), less than JW Pharmaceutical Corporation (26.74%), less than Dentium Co. Ltd. (5.28%), greater than Genomictree Inc. (-7.59%), less than JW Pharmaceutical Corporation (26.74%),
| Company | ROE | Market cap |
|---|---|---|
| -3.64% | $666.33B | |
| -0.98% | $501.28B | |
| 15.52% | $278.67B | |
| -16.37% | $212.42B | |
| 4.13% | $276.47B | |
| 0% | $401.48B | |
| 26.74% | $400.46B | |
| 5.28% | $313.48B | |
| -7.59% | $296.28B | |
| 26.74% | $609.67B |
Build a custom stock screener for Hyundai Bioscience Co., Ltd. (048410.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hyundai Bioscience Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hyundai Bioscience Co., Ltd. (048410.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hyundai Bioscience Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Hyundai Bioscience Co., Ltd.'s ROE?
How is the ROE calculated for Hyundai Bioscience Co., Ltd. (048410.KQ)?
What is the highest ROE for Hyundai Bioscience Co., Ltd. (048410.KQ)?
What is the 3-year average ROE for Hyundai Bioscience Co., Ltd. (048410.KQ)?
What is the 5-year average ROE for Hyundai Bioscience Co., Ltd. (048410.KQ)?
How does the current ROE for Hyundai Bioscience Co., Ltd. (048410.KQ) compare to its historical average?